ApniCure, Inc.

ApniCure, Inc.

ApniCure, Inc.

Date Founded



900 Chesapeake Drive,Redwood City, CA 94063

Type of Company


Employees (Worldwide)

11 - 50


Medical Products & Equipment
IT Consulting & Services
Hospitals & Patient Services
Holding Companies

Company Description

ApniCure, Inc. develops medical devices. It is a treatment option for adults with mild, moderate, and severe obstructive sleep apnea, designed without the inconvenience of a mask. The firm's Winx system uses a proprietary platform technology called oral pressure therapy to treat obstructive sleep apnea. The company was founded by Jonathan Podmore, Jhon Edwards Crowe, Chris Daniel and Matthias Vaska in 2007 and is headquartered in Redwood City, CA.

Contact Data
Trying to get in touch with decision makers at ApniCure, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees





Chief Business Officer

Chief Medical Advisor

Director-National Sales

Director-Research & Development

Board of Directors

Co-Founder at ApniCure, Inc.

General Partner at U.S. Venture Partners

Co-Founder, President at Quest Scholars Program, Inc.

Senior Advisor at U.S. Venture Partners

President, Chief Executive Officer & Director at Pulmonx Corp.

Co-Founder at AMP Resources LLC

Paths to ApniCure, Inc.
Potential Connections via
Relationship Science
ApniCure, Inc.
Recent Transactions
Details Hidden

ApniCure, Inc. raised money in a private placement transaction

Details Hidden

President, Chief Executive Officer & Director at Pulmonx Corp.

Details Hidden

Capricorn Investment Group invests in companies located in the US. The firm targets companies operating in the fields of broad range sectors. It provides financing for early stage capital requirements.

Details Hidden

Presidio Management Group invests in the information technology, clean technology and healthcare sectors. They are particularly interested in semiconductors, software as a service (SaaS), networking/storage solutions, wireless data, the Internet version 2.0, biomedical devices and new drugs with profound social benefits. They look for markets in excess of $1 billion in revenue potential and rarely invest in companies focusing on markets less than $300 million. Their investment horizon is 3 to 10 years.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by ApniCure, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of ApniCure, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and ApniCure, Inc..